Literature DB >> 16394278

Focal interstitial CC chemokine receptor 7 (CCR7) expression in idiopathic interstitial pneumonia.

E S Choi1, E M Pierce, C Jakubzick, K J Carpenter, S L Kunkel, H Evanoff, F J Martinez, K R Flaherty, B B Moore, G B Toews, T V Colby, E A Kazerooni, B H Gross, W D Travis, C M Hogaboam.   

Abstract

BACKGROUND/AIMS: Idiopathic interstitial pneumonias (IIPs) are a diverse grouping of chronic pulmonary diseases characterised by varying degrees of pulmonary fibrosis. The triggers of the fibroproliferative process in IIP remain enigmatic but recent attention has been directed towards chemokine involvement in this process.
METHODS: The expression of two chemokine receptors, CCR7 and CXCR4, and their respective ligands, CCL19, CCL21, and CXCL12, were examined in surgical lung biopsies (SLBs) from patients with IIP. Transcript and protein expression of these receptors and their ligands was compared with that detected in histologically normal margin SLBs.
RESULTS: CCR7 and CXCR4 were detected by gene array and real time polymerase chain reaction analysis and CCR7, but not CXCR4, expression was significantly raised in usual interstitial pneumonia (UIP) relative to biopsies from patients diagnosed with non-specific interstitial pneumonia (NSIP) or respiratory bronchiolitis/interstitial lung disease (RBILD). CCR7 protein was expressed in interstitial areas of all upper and lower lobe UIP SLBs analysed. CCR7 expression was present in 50% of NSIP SLBs, and CCR7 was restricted to blood vessels and mononuclear cells in 75% of RBILD SLBs. Immune cell specific CXCR4 expression was seen in IIP and normal margin biopsies. CCR7 positive areas in UIP biopsies were concomitantly positive for CD45 (the leucocyte common antigen) but CCR7 positive areas in all IIP SLBs lacked the haemopoietic stem cell antigen CD34, collagen 1, and alpha smooth muscle actin.
CONCLUSION: This molecular and immunohistochemical analysis showed that IIPs are associated with abnormal CCR7 transcript and protein expression.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16394278      PMCID: PMC1860265          DOI: 10.1136/jcp.2005.026872

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  49 in total

1.  Peripheral blood fibrocytes: differentiation pathway and migration to wound sites.

Authors:  R Abe; S C Donnelly; T Peng; R Bucala; C N Metz
Journal:  J Immunol       Date:  2001-06-15       Impact factor: 5.422

2.  Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair.

Authors:  R Bucala; L A Spiegel; J Chesney; M Hogan; A Cerami
Journal:  Mol Med       Date:  1994-11       Impact factor: 6.354

Review 3.  Chemokines: understanding their role in T-lymphocyte biology.

Authors:  S G Ward; J Westwick
Journal:  Biochem J       Date:  1998-08-01       Impact factor: 3.857

4.  Thin-section CT obtained at 10-mm increments versus limited three-level thin-section CT for idiopathic pulmonary fibrosis: correlation with pathologic scoring.

Authors:  E A Kazerooni; F J Martinez; A Flint; D A Jamadar; B H Gross; D L Spizarny; P N Cascade; R I Whyte; J P Lynch; G Toews
Journal:  AJR Am J Roentgenol       Date:  1997-10       Impact factor: 3.959

5.  Intracellular and surface expression of the HIV-1 coreceptor CXCR4/fusin on various leukocyte subsets: rapid internalization and recycling upon activation.

Authors:  R Förster; E Kremmer; A Schubel; D Breitfeld; A Kleinschmidt; C Nerl; G Bernhardt; M Lipp
Journal:  J Immunol       Date:  1998-02-01       Impact factor: 5.422

6.  Molecular cloning of a novel human CC chemokine secondary lymphoid-tissue chemokine that is a potent chemoattractant for lymphocytes and mapped to chromosome 9p13.

Authors:  M Nagira; T Imai; K Hieshima; J Kusuda; M Ridanpää; S Takagi; M Nishimura; M Kakizaki; H Nomiyama; O Yoshie
Journal:  J Biol Chem       Date:  1997-08-01       Impact factor: 5.157

7.  A chemokine expressed in lymphoid high endothelial venules promotes the adhesion and chemotaxis of naive T lymphocytes.

Authors:  M D Gunn; K Tangemann; C Tam; J G Cyster; S D Rosen; L T Williams
Journal:  Proc Natl Acad Sci U S A       Date:  1998-01-06       Impact factor: 11.205

Review 8.  Dynamic interactions between lung fibroblasts and leukocytes: implications for fibrotic lung disease.

Authors:  C M Hogaboam; R E Smith; S L Kunkel
Journal:  Proc Assoc Am Physicians       Date:  1998 Jul-Aug

Review 9.  Novel lymphocyte-specific CC chemokines and their receptors.

Authors:  O Yoshie; T Imai; H Nomiyama
Journal:  J Leukoc Biol       Date:  1997-11       Impact factor: 4.962

10.  6-C-kine (SLC), a lymphocyte adhesion-triggering chemokine expressed by high endothelium, is an agonist for the MIP-3beta receptor CCR7.

Authors:  J J Campbell; E P Bowman; K Murphy; K R Youngman; M A Siani; D A Thompson; L Wu; A Zlotnik; E C Butcher
Journal:  J Cell Biol       Date:  1998-05-18       Impact factor: 10.539

View more
  14 in total

Review 1.  The role of CXC chemokines in pulmonary fibrosis.

Authors:  Robert M Strieter; Brigitte N Gomperts; Michael P Keane
Journal:  J Clin Invest       Date:  2007-03       Impact factor: 14.808

2.  Circulating progenitor cells in chronic lung disease.

Authors:  Borna Mehrad; Michael P Keane; Brigitte N Gomperts; Robert M Strieter
Journal:  Expert Rev Respir Med       Date:  2007-08       Impact factor: 3.772

3.  Gene expression profiling of familial and sporadic interstitial pneumonia.

Authors:  Ivana V Yang; Lauranell H Burch; Mark P Steele; Jordan D Savov; John W Hollingsworth; Erin McElvania-Tekippe; Katherine G Berman; Marcy C Speer; Thomas A Sporn; Kevin K Brown; Marvin I Schwarz; David A Schwartz
Journal:  Am J Respir Crit Care Med       Date:  2006-09-22       Impact factor: 21.405

4.  New concepts of IL-10-induced lung fibrosis: fibrocyte recruitment and M2 activation in a CCL2/CCR2 axis.

Authors:  Lei Sun; Marisa C Louie; Kevin M Vannella; Carol A Wilke; Ann Marie LeVine; Bethany B Moore; Thomas P Shanley
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-12-03       Impact factor: 5.464

5.  Ursodeoxycholic acid exacerbates peginterferon-induced interstitial pneumonia in a patient with hepatitis C.

Authors:  Rena Kaneko; Masazumi Ogawa; Tomoyuki Iwata; Yasuyoshi An; Motoki Nakagawa; Satoshi Kusayanagi; Satoshi Kamisago; Tomoyuki Umeda; Yuzuru Sato
Journal:  Clin J Gastroenterol       Date:  2009-05-26

6.  Immunization with recombinant Pb27 protein reduces the levels of pulmonary fibrosis caused by the inflammatory response against Paracoccidioides brasiliensis.

Authors:  Elis Araujo Morais; Estefânia Mara do Nascimento Martins; Jankerle Neves Boelone; Dawidson Assis Gomes; Alfredo Miranda Goes
Journal:  Mycopathologia       Date:  2014-12-09       Impact factor: 2.574

7.  T regulatory cells and attenuated bleomycin-induced fibrosis in lungs of CCR7-/- mice.

Authors:  Glenda Trujillo; Adam J Hartigan; Cory M Hogaboam
Journal:  Fibrogenesis Tissue Repair       Date:  2010-09-03

8.  Therapeutic targeting of CC ligand 21 or CC chemokine receptor 7 abrogates pulmonary fibrosis induced by the adoptive transfer of human pulmonary fibroblasts to immunodeficient mice.

Authors:  Elizabeth M Pierce; Kristin Carpenter; Claudia Jakubzick; Steven L Kunkel; Kevin R Flaherty; Fernando J Martinez; Cory M Hogaboam
Journal:  Am J Pathol       Date:  2007-04       Impact factor: 4.307

9.  Integrated pharmacokinetic, pharmacodynamic and immunogenicity profiling of an anti-CCL21 monoclonal antibody in cynomolgus monkeys.

Authors:  S Dudal; K Subramanian; T Flandre; W S Law; P J Lowe; A Skerjanec; J-C Genin; M Duval; A Piequet; A Cordier; G Jarai; G Van Heeke; S Taplin; C Krantz; S Jones; A P Warren; F R Brennan; J Sims; P Lloyd
Journal:  MAbs       Date:  2015       Impact factor: 5.857

10.  An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias.

Authors:  William D Travis; Ulrich Costabel; David M Hansell; Talmadge E King; David A Lynch; Andrew G Nicholson; Christopher J Ryerson; Jay H Ryu; Moisés Selman; Athol U Wells; Jurgen Behr; Demosthenes Bouros; Kevin K Brown; Thomas V Colby; Harold R Collard; Carlos Robalo Cordeiro; Vincent Cottin; Bruno Crestani; Marjolein Drent; Rosalind F Dudden; Jim Egan; Kevin Flaherty; Cory Hogaboam; Yoshikazu Inoue; Takeshi Johkoh; Dong Soon Kim; Masanori Kitaichi; James Loyd; Fernando J Martinez; Jeffrey Myers; Shandra Protzko; Ganesh Raghu; Luca Richeldi; Nicola Sverzellati; Jeffrey Swigris; Dominique Valeyre
Journal:  Am J Respir Crit Care Med       Date:  2013-09-15       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.